Innate Pharma (IPHA) FCF Margin Growth (1y) (2020 - 2025)
Innate Pharma (IPHA) FCF Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | 811.00 |
| 10 | Innate Pharma | 202.48 Mn | 202.48 Mn | - | -183,634.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 193.00 |
| Dec 31, 2024 | 242.00 |
| Jun 30, 2024 | 340.00 |
| Dec 31, 2023 | 68.00 |
| Jun 30, 2023 | 0.00 |
| Dec 31, 2022 | -767.00 |
| Dec 31, 2021 | 605.00 |
| Dec 31, 2020 | -23.00 |